The deal would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.
from Health https://nyti.ms/2X3S9YM
June 25, 2019
Rose
Health, Health - The New York Times
No comments
Related Posts:
Schoolchildren Seem Unlikely to Fuel Coronavirus Surges, Scientists SayResearchers once feared that school reopenings might spread the virus through communities. But so far there is little evidence that it’s happening. from Health https://ift.tt/3kpodhb … Read More
Nurses Are at High Risk for Covid Among Health Workers, C.D.C. SaysA new study looked at the high numbers of health care workers hospitalized during the early months of the pandemic. from Health https://ift.tt/3ot9Zyg … Read More
Jeannette Williams-Parker, Nurse in a Virus Hot Spot, Dies at 48She was the first nurse in West Virginia to die of Covid-19. “She just never thought it would happen to her,” her mother said. from Health https://ift.tt/3krKTNQ … Read More
Do You Have the Heart for Marijuana?Research suggests that smoking marijuana carries many of the same cardiovascular health hazards as smoking tobacco. from Health https://ift.tt/31G3hLw … Read More
Respecting Children’s PainA new study challenges those who care for children to end what researchers say is the common undertreatment of pain in children, starting at birth. from Health https://ift.tt/37FDrem … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment